Mentice Bokslutskommuniké, Jan - Dec 2024
Läs mer
Mentice får en total order på avancerade simuleringslösningar värd $648,410 USD från ett topp 20 globalt medtech bolag
Läs Mer

Magnus Nilsson

Chairman of the Board
Chairman of the Remuneration Committee

Born 1956. Doctor of Medical Science (Med Dr Sc) from Uppsala University. Currently, Senior Advisor, XVIVO Perfusion Inc. Other Board assignments: board member at Cantargia AB and Corline AB. Earlier President and CEO, Xvivo Perfursion AB, President and CEO, Vitrolife AB and board member in the publicly listed Immunicum AB and Dignitana AB.

Holdings

Aktier och optioner

Shareholding in Mentice: 10,000 shares

Independent

Oberoende

Independent in relation to the company, its management, and major shareholders.

Mentice Year-end Report Q4, Oct - Dec 2024
Read more
Mentice Secures $648,410 USD Combined Order for Advanced Simulation Solutions from a Top 20 Global MedTech company
Learn More

Magnus Nilsson

Chairman of the Board
Chairman of the Remuneration Committee

Born 1956. Doctor of Medical Science (Med Dr Sc) from Uppsala University. Currently, Senior Advisor, XVIVO Perfusion Inc. Other Board assignments: board member at Cantargia AB and Corline AB. Earlier President and CEO, Xvivo Perfursion AB, President and CEO, Vitrolife AB and board member in the publicly listed Immunicum AB and Dignitana AB.

Holdings

Aktier och optioner

Shareholding in Mentice: 10,000 shares

Independent

Oberoende

Independent in relation to the company, its management, and major shareholders.